Pfizer said it was investigating the deaths of a Florida doctor who received one dose of the company’s COVID-19 vaccine.
The Centers for Disease Control and Prevention are also reportedly investigating the death of Gregory Michael, a 56-year-old obstetrician who was shot 16 days earlier.
Pfizer said there was no evidence yet that Michael’s death was caused by a vaccine developed by German biotech company BioNTech.
Pfizer in Manhattan calls it a “extremely unusual clinical case” of a condition known as severe thrombocytopenia, which limits the body’s ability to clot and stop bleeding.
“To date, millions of people have been vaccinated and we are closely monitoring all adverse events in our vaccinated people,”; Pfizer spokesman Jerica Pitts told The Post in a statement on the date. “It is important to note that serious adverse events, including non-vaccine-related deaths, are more likely to occur at rates similar to those occurring in the general population.”
The CDC is also aware of the deaths and “will assess the situation when more information is available,” agency spokeswoman Tom Skinner told Bloomberg.
Michael’s wife Heidi Neckelmann said in a Facebook post that her husband died of a stroke after spending two weeks in Miami Beach Hospital. She claimed his death was a “severe reaction to the COVID vaccine”, which she Said he received it on December 18.
“I believe people should be aware that side effects can occur. That’s not good for everyone and in this case destroys a beautiful life, a perfect family, and affects many people in the community,” Neckelmann said in a statement. The post added that her late husband was a “vaccine booster”.
However, Pfizer does not believe there is a link between the vaccine and the deaths from the vaccination clinical trial and “post-marketing experience to date,” Pitts said.
Pfizer’s vaccine is one of two vaccines that U.S. officials have cleared for emergency use as the country fights to contain the deadly COVID-19 epidemic, the other being developed by technology firm Moderna. Bio in Massachusetts
The CDC did not immediately respond to a request for comment as early as Wednesday.